日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Real-World Outcomes in Patients with Spinal Muscular Atrophy Treated with Onasemnogene Abeparvovec Monotherapy: Findings from the RESTORE Registry

使用 Onasemnogene Abeparvovec 单药治疗脊髓性肌萎缩症患者的真实世界结果:来自 RESTORE 注册研究的发现

Servais, Laurent; Day, John W; De Vivo, Darryl C; Kirschner, Janbernd; Mercuri, Eugenio; Muntoni, Francesco; Proud, Crystal M; Shieh, Perry B; Tizzano, Eduardo F; Quijano-Roy, Susana; Desguerre, Isabelle; Saito, Kayoko; Faulkner, Eric; Benguerba, Kamal M; Raju, Dheeraj; LaMarca, Nicole; Sun, Rui; Anderson, Frederick A; Finkel, Richard S

Combination disease-modifying treatment in spinal muscular atrophy: A proposed classification

脊髓性肌萎缩症的联合疾病修饰治疗:一种分类方案

Proud, Crystal M; Mercuri, Eugenio; Finkel, Richard S; Kirschner, Janbernd; De Vivo, Darryl C; Muntoni, Francesco; Saito, Kayoko; Tizzano, Eduardo F; Desguerre, Isabelle; Quijano-Roy, Susana; Benguerba, Kamal; Raju, Dheeraj; Faulkner, Eric; Servais, Laurent

PD-L1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics.

PD-L1 诊断测试:评分算法和测试验证指标的系统文献综述

Udall Margarita, Rizzo Maria, Kenny Juliet, Doherty Jim, Dahm SueAnn, Robbins Paul, Faulkner Eric